1 row is stored for this page
| Field | Field type | Value |
|---|
| generic | String | |
| brand | String | Ajovy |
| structure | File | |
| classes | List of String, delimiter: , | Anti-CGRP ligand monoclonal antibody |
| mechanism | String | Humanized IgG2 monoclonal antibody binding both isoforms of CGRP peptide |
| uses | String | Preventive treatment of migraine in adults (episodic and chronic) |
| starting_dose | String | 225 mg SC monthly, or 675 mg SC every 3 months (quarterly) |
| preparations | String | 225 mg/1.5 mL prefilled syringe or autoinjector |
| fda_max | String | 675 mg/quarter |
| pill_id | Text | |
| routes | List of String, delimiter: , | Subcutaneous |
| onset | String | Over weeks |
| duration | String | Monthly or quarterly dosing |
| halflife | String | ~31 days |
| bioavailability | String | Not formally established |
| pregnancy | String | Limited data; avoid |
| legal | String | Rx |
